These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3017981)

  • 21. Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine).
    Arai M; Inaba H; Higuchi M; Antonarakis SE; Kazazian HH; Fujimaki M; Hoyer LW
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4277-81. PubMed ID: 2498882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
    Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
    Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetics of hemophilia A.
    Gitschier J
    Schweiz Med Wochenschr; 1989 Sep; 119(39):1329-31. PubMed ID: 2508218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pathology and immunology of factor VIII (hemophilia A and factor VIII inhibitors).
    Hoyer LW
    Hum Pathol; 1987 Feb; 18(2):153-61. PubMed ID: 3100417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The physiology and pathophysiology of the factor VIII complex.
    Hamer RJ; Houdijk WP; Sixma JJ
    Crit Rev Oncol Hematol; 1986; 6(1):19-54. PubMed ID: 3096583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two novel missense mutations associated with hemophilia A in a family of Boxers, and a German Shepherd dog.
    Christopherson PW; Bacek LM; King KB; Boudreaux MK
    Vet Clin Pathol; 2014 Sep; 43(3):312-6. PubMed ID: 25040606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A modification of a method of evaluating the coagulation activity of factor VIII].
    Levchenko LB; Papaian LP; Kotovshchikova MA; Khrolova PV
    Lab Delo; 1989; (5):22-5. PubMed ID: 2473253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular pathogenesis of haemophilia A].
    Habart D
    Cas Lek Cesk; 2005; 144(11):727-32. PubMed ID: 16335697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of Factor VIII A2 Domain Residues 400-409 to a Factor X-Interactive Site in the Factor Xase Complex.
    Takeyama M; Nogami K; Sasai K; Furukawa S; Shima M
    Thromb Haemost; 2018 May; 118(5):830-841. PubMed ID: 29614522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the C2 domain of human factor VIII at 1.5 A resolution.
    Pratt KP; Shen BW; Takeshima K; Davie EW; Fujikawa K; Stoddard BL
    Nature; 1999 Nov; 402(6760):439-42. PubMed ID: 10586887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New characteristics of anti-factor VIII inhibitor antibody epitopes and unusual immune responses to Factor VIII.
    Scandella D
    Semin Thromb Hemost; 2002 Jun; 28(3):291-6. PubMed ID: 12098091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced thrombin sensitivity of a factor VIII-heparin cofactor II hybrid.
    Voorberg J; van Stempvoort G; Bos JM; Mertens K; van Mourik JA; Donath MJ
    J Biol Chem; 1996 Aug; 271(35):20985-8. PubMed ID: 8702860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological regulation of factor VIII activity.
    Kaufman RJ
    Annu Rev Med; 1992; 43():325-39. PubMed ID: 1580593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of dysfunctional factor VIII molecules.
    Hoyer LW
    Methods Enzymol; 1993; 222():169-76. PubMed ID: 8412792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evolving understanding of factor VIII binding sites and implications for the treatment of hemophilia A.
    Gilbert GE
    Blood Rev; 2019 Jan; 33():1-5. PubMed ID: 29866493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A HindIII RFLP and a gene lesion in the coagulation factor VIII gene.
    Bernardi F; Legnani C; Volinia S; Patracchini P; Rodorigo G; DeRosa V; Marchetti G
    Hum Genet; 1988 Apr; 78(4):359-62. PubMed ID: 2896159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin.
    Kane WH; Davie EW
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6800-4. PubMed ID: 3092220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a missense mutation in the factor VIII gene of a mild hemophiliac.
    Gitschier J; Wood WI; Shuman MA; Lawn RM
    Science; 1986 Jun; 232(4756):1415-6. PubMed ID: 3012775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.